CCM
BIVV

Cadence Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cadence Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-24,638
Closed -$1.33M – 718
2017
Q4 		$1.33M Sell
24,638
-344
-1% -$18.8K 0.08% 329
2017
Q3 		$1.43M Buy
+24,982
New +$1.46M 0.09% 301

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cadence Capital Management's BIVV Position: Q1 2018 in Review

Cadence Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 24,638 shares — an estimated $1.33M sold.

Cadence Capital Management first reported a position in BIVV in Q3 2017 and held it in 2 quarters. The position peaked at $1.43M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Cadence Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Cadence Capital Management sold 24,638 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $1.33M.
  • Cadence Capital Management first reported a position in Bioverativ Inc. Common Stock in Q3 2017 and held it in 2 quarters.
  • Cadence Capital Management's Bioverativ Inc. Common Stock position peaked at $1.43M in Q3 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Cadence Capital Management's 13F filing for Q1 2018, filed 14 May 2018.